"Heritage Valley Health System is an integrated delivery network providing comprehensive health care for residents of Allegheny, Beaver, Butler and Lawrence counties in Pennsylvania; eastern Ohio; and the panhandle of West Virginia. In partnership with 3,400 employees and more than 480 physicians, Heritage Valley offers a broad range of medical, surgical and diagnostic services at its two hospitals, Heritage Valley Sewickley and Heritage Valley Beaver; in 60 physician offices; and 18 community satellite facilities."

During the past decade, UPMC-Heritage Valley Health System Beaver conducted 89 clinical trials. In the 10-year time frame, 89 clinical trials started and 53 clinical trials were completed, i.e. on average, 59.6% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 43 clinical trials were completed. i.e. 130.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UPMC-Heritage Valley Health System Beaver" #1 sponsor was "National Cancer Institute (NCI)" with 36 trials, followed by "SWOG Cancer Research Network" with 15 trials sponsored, "Eli Lilly and Company" with 14 trials sponsored, "Alliance for Clinical Trials in Oncology" with 13 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 13 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UPMC-Heritage Valley Health System Beaver" #1 collaborator was "National Cancer Institute (NCI)" with 47 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "UPMC-Heritage Valley Health System Beaver" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Type 2 Diabetes" (7 trials), "Stage II Breast Cancer" (6 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "UPMC-Heritage Valley Health System Beaver" in a lesser frequency.

Most popular intervention types in "UPMC-Heritage Valley Health System Beaver" are "Drug" (95 trials), "Other" (58 trials), "Biological" (33 trials), "Procedure" (26 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (22 trials), "Cisplatin" (17 trials), "Docetaxel" (14 trials) and "Placebo" (14 trials). Other intervention names were less common.

The vast majority of trials in "UPMC-Heritage Valley Health System Beaver" are 99 trials for "All" genders, 13 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "UPMC-Heritage Valley Health System Beaver". undefined are not yet recruiting, 27 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in UPMC-Heritage Valley Health System Beaver, 3 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in UPMC-Heritage Valley Health System Beaver, 0 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 64 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 9 trials that are defined as “Not Applicable".

UPMC-Heritage Valley Health System Beaver has several departments that took part in Clinical trials: "The Heart and Vascular Center" - 2 trials, "Sewickley Valley Medical Group, Cardiology" - 2 trials